Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab in Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2